Venus Remedies Limited, a pharmaceutical company, manufactures and trades in medicines in India and internationally. The company's flagship product is Elores, a novel antibiotic adjuvant entity containing a beta-lactam antibiotic. Its products also include Potentox, which works in multi drug resistant gram negative pathogens in aminoglycoside and quinolone resistance where other drugs fail to respond; Vancoplus that is active against pathogens; and VRP-001, VRT 001-M, VRT 001-C, VRT 001-V, and VRP–032 oral antibiotic adjuvant entities based on stealth targeted nanoparticle technology. The company offers its products in various therapeutic segments comprising analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin care, stress reliever, urology, vitamins/minerals/nutrients, and wound management. The company was incorporated in 1989 and is headquartered in Panchkula, India. The ISIN of this stock is INE411B01019.